Peak Serum, Inc. Appoints Interim CEO

Michael Dodge, Chief Executive Officer (Interim), Peak Serum, Inc.
Michael Dodge, Peak's current global director of sales has been tapped as Peak's interim CEO.

WELLINGTON, Colo. - February 2, 2021 - (Newswire.com)

Effectively immediately, Thomas Kutrubes has been removed from privately owned and independent supplier of life science laboratory products — Peak Serum, Inc. (Peak) — by the chief restructuring officer and Trustee, Jay Roderick. Michael Dodge, Peak's current global director of sales has been tapped as Peak's interim CEO. 

Dodge has more than 20 years of experience in the life science industry, having worked in both domestic and international markets and has been with Peak since May 2019.

Roderick commented: "Restructuring is underway, and the company has a bright future! During this time of change, it is important that Peak has a CEO in place that has the experience and industry knowledge to ensure Peak's customers receive the highest level of service. Michael Dodge has established and successfully led several companies in the United Kingdom for U.S.-based entities. He has also established several European distribution networks for U.S. organizations as well as for Peak. Dodge has proven to me that he is capable, driven, and professionally qualified to assume this crucial role."

Peak Serum, Inc. is a privately owned and independent supplier of life science laboratory products and serums for cGMP / clinical trial research and diagnostics applications. Peak Serum was founded in 2015 as a cGMP supplier of U.S. and USDA-approved FBS products. Since 2019, Peak has expanded its portfolio, which now includes private-labeled liquid handling and tissue culture products, as well as nitrile gloves.

-###-

About Peak Serum, Inc.
Based in Wellington, Colorado, Peak Serum is one of the nation's leading independent suppliers of fetal bovine serum, an essential part of cGMP / clinical trial research and diagnostics applications. For more information on Peak Serum, visit www.peakfbs.com. 

For questions regarding this release or the restructure effort contact:
Jay Roderick
Chief Restructuring Officer / Trustee
404.576.9879
jay@peakfbs.com

For questions about Peak's business or product offerings contact:
Michael Dodge
Chief Executive Officer (Interim)
925.788.1025
michael@peakfbs.com

Press Release Service by Newswire.com

Original Source: Peak Serum, Inc. Appoints Interim CEO